XML 30 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares and Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss, Net of Tax
Non-redeemable Non-controlling Interests
Beginning Balance (in shares) at Dec. 31, 2021   214.8      
Beginning Balance at Dec. 31, 2021 $ 1,158 $ 6,626 $ (1,694) $ (3,871) $ 97
Increase (Decrease) in Shareholders' Equity          
Net income 2,646   2,589   57
Shares issued — employee stock compensation plans (in shares)   1.7      
Shares issued — employee stock compensation plans (157) $ (156) (1)    
Shares repurchased (in shares)   (11.1)      
Shares repurchased (3,203)   (3,203)    
Share-based compensation expense 397 $ 397      
Dividends to shareholders (463)   (463)    
Net change in fair value of financial instruments (13)     (13)  
Net foreign currency translation adjustments (528)     (528)  
Net postretirement benefit obligation (211)     (211)  
Net purchases of shares from nonredeemable noncontrolling interests (2) $ (1)     (1)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (53)       (53)
Ending Balance (in shares) at Dec. 31, 2022   205.4      
Ending Balance at Dec. 31, 2022 (429) $ 6,866 (2,772) (4,623) 100
Increase (Decrease) in Shareholders' Equity          
Net income 2,628   2,564   64
Shares issued — employee stock compensation plans (in shares)   1.6      
Shares issued — employee stock compensation plans (169) $ (168) (1)    
Shares repurchased (in shares)   (8.4)      
Shares repurchased (2,700)   (2,700)    
Share-based compensation expense 438 $ 438      
Dividends to shareholders (490)   (490)    
Net change in fair value of financial instruments 13     13  
Net foreign currency translation adjustments 276     277 (1)
Net postretirement benefit obligation (40)     (40)  
Net purchases of shares from nonredeemable noncontrolling interests (213) $ (190)     (23)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock $ (56)       (56)
Ending Balance (in shares) at Dec. 31, 2023 198.6 198.6      
Ending Balance at Dec. 31, 2023 $ (742) $ 6,946 (3,399) (4,373) 84
Increase (Decrease) in Shareholders' Equity          
Net income 2,720        
Net income [1] 2,715   2,654   61
Shares issued - NFP Transaction (In shares)   19.0      
Shares issued - NFP Transaction 5,882 $ 5,882      
Shares issued — employee stock compensation plans (in shares)   1.5      
Shares issued — employee stock compensation plans (124) $ (123) (1)    
Shares repurchased (in shares)   (3.1)      
Shares repurchased (1,000)   (1,000)    
Share-based compensation expense 474 $ 474      
Dividends to shareholders (563)   (563)    
Net change in fair value of financial instruments 72     72  
Net foreign currency translation adjustments (467)     (467)  
Net postretirement benefit obligation 23     23  
Net purchases of shares from nonredeemable noncontrolling interests 83 (1)     84
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (45)       (45)
Adjustments to redeemable noncontrolling interests $ (3) $ (3)      
Ending Balance (in shares) at Dec. 31, 2024 216.0 216.0      
Ending Balance at Dec. 31, 2024 $ 6,305 $ 13,175 $ (2,309) $ (4,745) $ 184
[1] The Company’s Net income totaled $2.7 billion for the year ended December 31, 2024, which included $5 million of Net income related to redeemable noncontrolling interests.